Cytokeratin 19 (CK19) forms intermediate filaments found in the intracytoplasmic cytoskeleton of epithelial tissue and provides mechanical support. Anti-Cytokeratin 19 stains epithelia and epithelial malignancies such as carcinomas of the colon, stomach, pancreas, biliary tract, liver, and breast. Cytokeratin 19 is a useful marker for distinguishing hepatocellular carcinoma from intrahepatic cholangiocarcinoma. This differentiation is improved when stained in combination with Cytokeratin 7, CAM5.2, Ber-EP4/MOC31, Hep-Par1, and TTF1. Cytokeratin 19 staining can also be used to recognize thyroid papillary carcinomas.

• Cytokeratin 19 IVDR Datasheet

• MSDS

CLONE:
IHC019

ISOTYPE:
IgG1

HOST SPECIES:
Mouse

CLONALITY:
Monoclonal

POSITIVE CONTROL:
Bladder, Colon Carcinoma, Colon, Thyroid Carcinoma

DILUTION RANGE:


INTENDED USE/REG. STATUS:
IVDR